Post-hoc analysis of sequential afatinib and osimertinib in NSCLC patients Video Journal of Biomedicine 9:27 2 years ago 1 069 Далее Скачать
Sequential afatinib and osimertinib in EGFR mutation-positive NSCLC patients: updated results Future Science Group 6:43 5 years ago 1 908 Далее Скачать
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive NSCLC Future Science Group 6:28 6 years ago 2 005 Далее Скачать
Study of 693 NSCLC patients treated with afatinib Video Journal of Biomedicine 8:47 2 years ago 1 250 Далее Скачать
EGFR Mutated NSCLC Disease Progression on Osimertinib - 2022 Program: Targeted Therapies Forum GRACE - Global Resource for Advancing Cancer Education 3:20 2 years ago 221 Далее Скачать
GioTag: real world data on first-line afatinib followed by osimertinb VJOncology 2:34 5 years ago 206 Далее Скачать
First-line osimertinib in EGFR mutant aNSCLC patients: Progression pattern and safety in the rea... ecancer 5:26 3 years ago 179 Далее Скачать
FLAURA final analysis: osimertinib for first-line EGFRm NSCLC VJOncology 8:44 5 years ago 2 119 Далее Скачать
How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC HMP Education 17:27 8 years ago 5 605 Далее Скачать
Tumor clonality in EGFR mutation-positive NSCLC Future Science Group 10:30 5 years ago 6 079 Далее Скачать
Dr. Kris on Predicting Benefit With Osimertinib in EGFR+ NSCLC OncLive 1:40 5 years ago 278 Далее Скачать
ADAURA Study Demonstrates Promising Efficacy for Osimertinib in EGFR-Mutant NSCLC Targeted Oncology 0:58 4 years ago 518 Далее Скачать
